Search results for: 'Digitalization of Pharma Value Chain'

21 Jan 2025  |  Global  |  Technology Research

Technologies Enabling Resilient Pharmaceutical Supply Chains

AI-enabled Technologies are Transforming the Pharmaceutical Supply Chain Network

Infographics

×

This study aims to review emerging, transformative technology solutions that redesign pharmaceutical supply chain processes and introduce increased resilience, transparency, and responsiveness into the model. The study answers the following questions: What are some new challenges big pharma's supply chains must address today? How can emerging tec...

The biopharma industry has been evolving over the past few decades. This study analyses the top ten trends that will impact the future of the biopharma industry through 2040.The future of biopharma will be driven by innovation in AI and ML, particularly generative AI, and by advancements in translational medicine and synthetic biology. Future clini...

The Trend Opportunity Profiles Series covers specific opportunities emerging from future trend evolutions designed to help clients discover and prioritize the most consequential medium- to long-term trends that are continually transforming their business growth environment. These trend opportunity profiles cover 12 key industries: aerospace and def...

31 Dec 2019  |  Global  |  Market Research

Strategic Analysis of Global Shared Mobility Value Chain, Forecast to 2030

Disruptive Technologies, OEM and Operator Partnerships, and Investments will Drive the Mobility Value Chain in the Future

Infographics

×

The study aims to analyse and forecast the global mobility value chain and technology trends for 2018. Shared mobility companies depend heavily on aftermarket service providers for procuring fleet, conducting maintenance and repairs, and deploying technology for smooth operations. Shared mobility partnerships are increasing the presence of the valu...

Adoption of software supply chain security (SSCS) solutions will maintain steady growth during the next 5 years, mainly because of increasing SSCS risks that result from digitization; the inability of traditional application security approaches to safeguard applications or address SSCS; the surging use of open-source and third-party code, tools, an...

The pharmaceutical and biotechnology industries are entering a transformative era in 2025, shaped by a convergence of scientific innovation, regulatory evolution, and market pressures. One of the key imperatives is the continued advancement of therapeutics and drug approvals, as breakthrough treatments, particularly in personalized medicine, promis...

The Trend Opportunity Profiles Series identifies specific opportunities emerging from future trend evolutions. It is designed to help clients discover and prioritize the most consequential medium-to-long-term trends that are continually transforming their business’s growth environment. The series covers 9 key industries: Supply chain and logistics;...

In the post-pandemic global business ecosystem, all eyes remain trained on supply chains as operations inch toward a new normal characterized by transparency and business resilience. In this study, Frost & Sullivan discusses the top growth opportunities for the fast-evolving supply chain and logistics domain, particularly how technologies, inclu...

Transformative technologies are poised to redefine traditional supply chain operations as businesses navigate cost management challenges, rising goods costs, and geopolitical influences on production and distribution toward a new normal characterized by transparency and resilience. Digital transformation and technology integration are integral to e...